Loading...
Shanghai Henlius Biotech, Inc.
2696.HK•HKSE
Healthcare
Biotechnology
HK$67.25
HK$-2.75(-3.93%)
Shanghai Henlius Biotech, Inc. (2696.HK) Financial Performance & Income Statement Overview
Review Shanghai Henlius Biotech, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.11%
↑ 6.11%
Operating Income Growth
48.67%
↑ 48.67%
Net Income Growth
50.26%
↑ 50.26%
Operating Cash Flow Growth
18.51%
↑ 18.51%
Operating Margin
15.14%
↑ 15.14%
Gross Margin
73.10%
↑ 73.10%
Net Profit Margin
14.33%
↑ 14.33%
ROE
29.35%
↑ 29.35%
ROIC
15.57%
↑ 15.57%
Shanghai Henlius Biotech, Inc. (2696.HK) Income Statement & Financial Overview
Review Shanghai Henlius Biotech, Inc.'s (2696.HK) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $1.49B | $1.49B | $1.37B | $1.37B |
Cost of Revenue | $392.19M | $392.19M | $377.71M | $377.71M |
Gross Profit | $1.10B | $1.10B | $995.35M | $995.35M |
Gross Profit Ratio | $0.74 | $0.74 | $0.72 | $0.72 |
R&D Expenses | $276.33M | $276.33M | $241.23M | $241.23M |
SG&A Expenses | $611.43M | $611.43M | $530.08M | $530.08M |
Operating Expenses | $887.76M | $887.76M | $771.32M | $771.32M |
Total Costs & Expenses | $1.28B | $1.28B | $1.15B | $1.15B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $69.91M | $69.14M | $69.14M | $69.14M |
EBITDA | $279.13M | $278.36M | $293.17M | $293.17M |
EBITDA Ratio | $0.19 | $0.19 | $0.21 | $0.21 |
Operating Income | $209.22M | $209.22M | $224.03M | $224.03M |
Operating Income Ratio | $0.14 | $0.14 | $0.16 | $0.16 |
Other Income/Expenses (Net) | $15.86M | $15.86M | -$26.17M | -$26.17M |
Income Before Tax | $225.08M | $225.08M | $197.86M | $197.86M |
Income Before Tax Ratio | $0.15 | $0.15 | $0.14 | $0.14 |
Income Tax Expense | $8.00M | $8.00M | $4.71M | $4.71M |
Net Income | $217.08M | $217.08M | $193.15M | $193.15M |
Net Income Ratio | $0.15 | $0.15 | $0.14 | $0.14 |
EPS | $0.40 | $0.40 | $0.36 | $0.36 |
Diluted EPS | $0.40 | $0.40 | $0.36 | $0.36 |
Weighted Avg Shares Outstanding | $543.50M | $543.50M | $544.09M | $544.09M |
Weighted Avg Shares Outstanding (Diluted) | $543.49M | $543.49M | $543.49M | $543.49M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan